Somnomed Limited (AU:SOM) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
SomnoMed Limited reported a net positive cash flow from operations of AUD 1.12 million for the quarter ending September 2024, indicating healthy customer receipts despite substantial expenses in staff and manufacturing. The company’s net cash position improved by AUD 16.18 million, although they witnessed a cash outflow in investing and financing activities. This financial performance showcases SomnoMed’s solid operational footing in a challenging economic landscape.
For further insights into AU:SOM stock, check out TipRanks’ Stock Analysis page.